Our Distinguished Speaker Series (DSS) has contributed to broadening the dynamic educational experience of Merage School students and the community by bringing influential leaders to campus, encouraging thought-provoking conversations and the exchange of ideas. Through DSS-sponsored lectures and collaborations, we strive to achieve our mission of being at the forefront of thought-leadership and academic excellence.
Our enviable list of distinguished speakers comes from across the globe, and through the sharing of their experiences and stories, they challenge our newest generation to make a difference in society and business. The series highlights leadership perspectives, ethical frameworks, decision-making processes, and insights of top business leaders from different industries. This is also a great opportunity to network with approximately 300 corporate professionals, community leaders, students, faculty members and campus staff.
Featuring Ronalee Zarate-Bayani Chief Marketing Officer, Los Angeles Rams
Wednesday, February 20, 2019 6:30 p.m. - 7:30 p.m UCI Merage School Auditorium
Innovation and Disruption: A 25-Year-Career in the Tech Industry
For over two decades, Brent Callinicos, COO/CFO of Virgin Hyperloop One, has distinguished himself as a force in tech, building his career in finance at Microsoft, Google, Uber and Hyperloop One. Join us as he shares his career and life experiences at these innovative companies.
Virgin Hyperloop One is a Los Angeles based company working to commercialize the Hyperloop for moving passengers and/or cargo at airline speeds at a fraction of the cost of air travel.
February 15, 2018
New Leadership Requirements for a Digitally Driven World
GE has undergone an ambitious transformation, repositioning itself as the world’s premier digital industrial company. Join us to hear Jeff Erhardt, Vice President of Intelligent Systems of GE Digital, discuss how the 125-year-old company sees the world changing, how they are adapting, and what new managerial capabilities are required for success. Learn how GE is reinventing itself, and what it means for your company and its future.
November 6, 2017
How to Drive Sustainable Corporate Performance – Experiences from the Front Line
The Winter 2017 Distinguished Speaker Series, presented by TheCenter for Global Leadership, highlights the leadership perspectives, ethical frameworks, decision making processes and insights of top business leaders in the industry. This is a great opportunity to network with approximately 300 corporate professionals, community leaders, MBA students, faculty members and campus staff.
During Dr. Pyott's 17 year tenure, Allergan was transformed from a small eye care business with about $1 billion in sales to a global specialty pharmaceutical and medical device company, with sales over $7 billion in 2014 with most of the increase stemming from organic growth. Allergan’s market capitalization increased from $2.3 billion in 1998 to $72 billion when Allergan was acquired by Actavis in 2015. Dr. Pyott was recognized by Harvard Business Review as one of “The 100 Best Performing CEOs in the World” in 2014 (ranked #4). He has lived in 10 countries and worked in 7 countries ranging from the U.S. to Europe and Asia.
In 2006, Dr. Pyott was bestowed with the honor of Commander of the Most Excellent Order of the British Empire (CBE) by Her Majesty the Queen. Dr. Pyott holds a Diploma in International and European Law from the Europa Institute at the University of Amsterdam, a Master of Arts degree and an Honorary Degree in Medicine from the University of Edinburgh and a Master of Business Administration degree from the London Business School. Dr. Pyott is Lead Director and a member of the Board of Directors of Avery Dennison Corporation, a member of the Board of Alnylam Pharmaceuticals Inc., BioMarin Pharmaceutical Inc., a member of the Supervisory Board of Royal Philips in the Netherlands and Chairman of Bioniz Therapeutics. He is a Governor of London Business School, President of the International Council of Ophthalmology Foundation and is also involved on the Boards of many of the other US and international eyecare charities.